Lifetime Achievement

CIMT Lifetime Achievement Award

The CIMT Lifetime Achievement Award honors a European researcher who has significantly contributed to the advancement of cancer immunotherapy. The award was inaugurated in 2017 and is bestowed every other year.

2023

The German immunologist Hans-Georg Rammensee is the recipient of the 2023 CIMT Lifetime Achievement Award. He is recognized for his extraordinary achievements in cancer immunology, in particular the understanding of peptide-antigen presentation on MHC molecules and his seminal work on personalized cancer vaccination. He was honored on May 4, at the 20th CIMT Annual Meeting in Mainz, Germany. Read more

2021

The 2021 Lifetime Achievement Award was bestowed on Alberto Mantovani for his work on the molecular mechanisms of innate immunity and inflammation. Over his 50-year career, Alberto Mantovani has significantly advanced knowledge in the field of immunology by formulating new paradigms and identifying new molecules and functions. In addition, he has furthered awareness of science and medicine by authoring books and articles on immunology, vaccines and health targeted at the general public. Read more

2019

On May 21, 2019, Wolf Herman Fridman was honored for his outstanding contribution to a deeper understanding of cancer immunology and the tumor environment. His broad research interests over a long career have influenced facets in the field, from basic cancer immunology to clinical prognosis. His work and mentorship have given rise to a new generation of scientific leaders in European cancer immunology. Wolf Fridman is professor emeritus at Paris Descartes University as well as the founder of Cordeliers Research Centre, and president of the Canceropole Ile de France.

2017

In 2017, the CIMT Awards Committee has chosen Cornelis Melief to be the first recipient of this biennial award that celebrates the dedication, ingenuity, and impactful success of a researcher who has dedicated his life’s work to finding immunological treatment options for cancer patients. Internationally recognized for his insights into the relationship between tumors and the immune system and for his clinical research and development of innovative cell therapies and therapeutic vaccines, Cornelis Melief has provided leadership for a generation of European scientists.